Workiva (WK) 10-Q2021 Q3 Quarterly report

Filed: 3 Nov 21, 4:20pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: Adequate, approach, approval, assembled, Biden, call, case, clause, comply, consecutive, contractor, coordinate, COVID, Department, distancing, DOL, drafted, efficacy, ensure, Ensuring, exceeded, externally, hospitalization, House, infection, insignificant, intent, Labor, life, lose, macroeconomy, main, manner, manufacture, masking, memorandum, met, national, newly, notice, November, October, onsite, original, OSHA, ownership, par, preceding, precise, preliminarily, preliminary, recurrence, redeem, redeemed, redemption, refine, remeasured, Safer, settle, Task, trajectory, unanswered, unpaid, unvaccinated, vaccinated, vaccination, vaccine, variant, voluntarily, week, weekly, White, workplace

Removed: agreed, application, broader, Council, currency, delay, easier, Electronic, ESEF, European, FCA, foreign, GRC, Kingdom, package, policy, reduction, Union

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

Associated WK transcripts

WK similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

CERTIFICATION UNDER SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

I, Martin J. Vanderploeg, President and Chief Executive Officer of Workiva Inc. (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1.the Quarterly Report on Form 10-Q of the Company for the period ended September 30, 2021 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2.the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein.



November 3, 2021						/s/ Martin J. Vanderploeg, Ph.D. Martin J. Vanderploeg, Ph.D. President and Chief Executive Officer (Principal Executive Officer)